Cleve Clin J Med. 2023 Oct 2;90(10):632-639. doi: 10.3949/ccjm.90a.23023.
ABSTRACT
Portopulmonary hypertension, ie, pulmonary arterial hypertension in a patient with portal hypertension, affects transplant eligibility and has a poor prognosis. The pathogenesis remains an area of active research, with various mechanisms proposed. Diagnosing it requires a detailed history, physical examination, laboratory tests, and echocardiographic evaluation, followed by a careful hemodynamic assessment.
PMID:37783493 | DOI:10.3949/ccjm.90a.23023